Jessica Kappelman, MD
Dermatology · Plainfield, ILNPI 1376707448
Payments from drug & device makers
Across 916 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$2K
- Pfizer$1K
- Sanofi$1K
- Galderma Laboratories, L.p.$1K
- Novartis$852
- plus $8K from 30 others
What the payments were for
- Food & beverage$16,01195%
- Education$8355%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 135 | $2,493 |
| AbbVie(2 entities) | 121 | $2,052 |
| Pfizer | 70 | $1,197 |
| Sanofi | 53 | $1,189 |
| Galderma Laboratories, L.p. | 67 | $1,114 |
| Novartis | 36 | $852 |
| Mayne Pharma Commercial LLC | 59 | $841 |
| Regeneron Healthcare Solutions, Inc. | 30 | $822 |
| VYNE Pharmaceuticals Inc. | 38 | $794 |
| UCB, Inc. | 22 | $703 |
| Incyte Corporation | 45 | $682 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 45 | $641 |
| Amgen | 44 | $627 |
| Arcutis Biotherapeutics, Inc. | 38 | $435 |
| Sun Pharmaceutical Industries Inc. | 22 | $410 |
| Janssen Scientific Affairs, LLC | 3 | $331 |
| LEO Pharma Inc. | 19 | $322 |
| Lilly USA, LLC | 15 | $310 |
| Dermira, Inc. | 11 | $210 |
| E.r. Squibb & Sons, L.L.C. | 9 | $145 |
| Sanofi-aventis U.S. LLC | 2 | $103 |
| Dermavant Sciences, Inc. | 5 | $93 |
| Organon | 4 | $88 |
| EPI Health, LLC | 5 | $84 |
| Journey Medical Corporation | 4 | $70 |
| Biofrontera Inc. | 3 | $50 |
| Boehringer Ingelheim | 2 | $41 |
| Verrica Pharmaceuticals Inc. | 1 | $27 |
| LNHC, Inc | 1 | $24 |
| Mylan Pharmaceuticals Inc. | 1 | $18 |
| Encore Dermatology Inc. | 1 | $17 |
| Almirall LLC | 1 | $16 |
| Sebela Pharmaceuticals Inc. | 1 | $14 |
| Mission Pharmacal Company | 1 | $14 |
| Aclaris Therapeutics, Inc. | 1 | $11 |
| Sensus Healthcare, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,846 in reported general payments places this provider in the 80th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 36 | $1,547 |
| Betamethasone Dipropionate | 14 | $671 |
| Triamcinolone Acetonide | 42 | $532 |
| Fluticasone Propionate | 31 | $389 |
| Ketoconazole | 14 | $225 |
| Minoxidil | 24 | $159 |
| ValacyclovirValacyclovir Hcl | 14 | $129 |
| Mupirocin | 11 | $51 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Plainfield
- Michael BukhaloRolling Meadows$6.8M
- Stephanie MehlisSkokie$6.4M
- Ahmad AminNaperville$4.6M
- George LewittNorthbrook$4M
- Raj ChovatiyaChicago$3.7M
- Peter LioChicago$2.5M
- Paul GetzWest Dundee$2.4M
- Kyle AmberBerwyn$2.3M
- Elizabeth KiracofeChicago$1.6M
- Lana SchmidtEffingham$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.